Literature DB >> 19766213

[Laparoscopic splenectomy: indications, techniques, outcomes].

F Borie1, C Philippe.   

Abstract

Laparoscopic splenectomy (LS) has become the standard approach to splenectomy for benign and malignant hematologic diseases despite a paucity of high-level evidence. The procedure requires expertise in laparoscopic surgical techniques and meticulous dissection of the spleen. Management should include a preoperative radiologic assessment to measure splenic volume and to detect the presence of accessory splenic tissue; the patient should undergo preoperative vaccination against meningococcal, pneumococcal, and Haemophilus influenzae type B infections. Prophylactic antibiotics are used in the perioperative period as well as prophylactic anticoagulation therapy which may be continued long-term in high-risk patients. LS is associated with a low morbidity and mortality; when compared to laparotomy, it reduces the length of hospital stay and improves the quality of life by decreasing postoperative ileus and pain. There are a variety of laparoscopic approaches; the hand-assisted technique and newer coagulating devices have facilitated the operative technique leading to increasing acceptance of laparoscopy as the preferred approach - even in patients with malignant hematologic disease and/or massive splenomegaly.

Entities:  

Mesh:

Year:  2009        PMID: 19766213     DOI: 10.1016/j.jchir.2009.08.030

Source DB:  PubMed          Journal:  J Chir (Paris)        ISSN: 0021-7697


  2 in total

1.  Is expertise in pediatric surgery necessary to perform laparoscopic splenectomy in children? An experience from a department of general surgery.

Authors:  Marcello Guaglio; Fabrizio Romano; Mattia Garancini; Luca Degrate; Margherita Luperto; Fabio Uggeri; Mauro Scotti; Franco Uggeri
Journal:  Updates Surg       Date:  2012-01-13

2.  Laparoscopic splenectomy for solitary splenic metastasis in patients with previous open surgery-Case series.

Authors:  Dobromir Dimitrov Dimitrov
Journal:  Int J Surg Case Rep       Date:  2019-10-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.